Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Using Cell-Free DNA 5-Hydroxymethylation Signatures

David Haan, Anna Bergamaschi, Gulfem D Guler, Verena Friedl, Yuhong Ning, Roman Reggiardo, Michael Kesling, Micah Collins, Bill Gibb, Adriana Pitea, Kyle Hazen, Steve Bates, Michael Antoine, Carolina Fraire, Vanessa Lopez, Roger Malta, Maryam Nabiyouni, Albert Nguyen, Tierney Phillips, Michael Riviere, Aaron Scott, Eric Nilson, Judy Sheard, Melissa Peters, Shimul Chowdhury, Wayne Volkmuth, Samuel Levy
doi: https://doi.org/10.1101/2021.12.27.21268450
David Haan
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dhaan@bluestargenomics.com
Anna Bergamaschi
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gulfem D Guler
2Bluestar Genomics, 155 Bovet Road, Suite 400, San Mateo, California 94402
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Verena Friedl
2Bluestar Genomics, 155 Bovet Road, Suite 400, San Mateo, California 94402
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuhong Ning
2Bluestar Genomics, 155 Bovet Road, Suite 400, San Mateo, California 94402
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roman Reggiardo
2Bluestar Genomics, 155 Bovet Road, Suite 400, San Mateo, California 94402
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Kesling
2Bluestar Genomics, 155 Bovet Road, Suite 400, San Mateo, California 94402
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Micah Collins
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bill Gibb
2Bluestar Genomics, 155 Bovet Road, Suite 400, San Mateo, California 94402
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriana Pitea
2Bluestar Genomics, 155 Bovet Road, Suite 400, San Mateo, California 94402
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyle Hazen
2Bluestar Genomics, 155 Bovet Road, Suite 400, San Mateo, California 94402
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Bates
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Antoine
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolina Fraire
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanessa Lopez
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Malta
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maryam Nabiyouni
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Nguyen
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tierney Phillips
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Riviere
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron Scott
2Bluestar Genomics, 155 Bovet Road, Suite 400, San Mateo, California 94402
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Nilson
2Bluestar Genomics, 155 Bovet Road, Suite 400, San Mateo, California 94402
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judy Sheard
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Peters
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shimul Chowdhury
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wayne Volkmuth
2Bluestar Genomics, 155 Bovet Road, Suite 400, San Mateo, California 94402
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel Levy
1Bluestar Genomics, 10578 Science Center Drive, Suite 210, San Diego, California 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

BACKGROUND Pancreatic cancer (PaC) has poor (10%) 5-year overall survival, largely due to predominant late-stage diagnosis. Patients with new-onset diabetes (NOD) are at a six-to eightfold increased risk for PaC. We developed a pancreatic cancer detection test for the use in a clinical setting that employs a logistic regression model based on 5-hydroxymethylcytosine (5hmC) profiling of cell-free DNA (cfDNA).

METHODS cfDNA was isolated from plasma from 89 subjects with PaC and 596 case-control non-cancer subjects, and 5hmC libraries were generated and sequenced. These data coupled with machine-learning, were used to generate a predictive model for PaC detection, which was independently validated on 79 subjects with PaC, 163 non-cancer subjects, and 506 patients with non-PaC cancers.

RESULTS The area under the receiver operating characteristic curve for PaC classification was 0.93 across the training data. Training sensitivity was 58.4% (95% confidence interval [CI]: 47.5– 68.6) after setting a classification probability threshold that resulted in 98% (95% CI: 96.5–99) specificity. The independent validation dataset sensitivity and specificity were 51.9% (95% CI: 40.4–63.3) and 100.0% (95% CI: 97.8–100.0), respectively. Early-stage (stage 1 and 2) PaC detection was 47.6% (95% CI: 23%–58%) and 39.4% (95% CI: 32%–64%) in the training and independent validation datasets, respectively. Sensitivity and specificity in NOD patients were 55.2% [95% CI: 35.7–73.6] and 98.4% [95% CI: 91.3–100.0], respectively. The PaC signal was identified in intraductal papillary mucinous neoplasm (64%), pancreatitis (56%), and non-PaC cancers (17%).

CONCLUSIONS The pancreatic cancer detection assay showed robust performance in the tested cohorts and carries the promise of becoming an essential clinical tool to enable early detection in high-risk NOD patients.

Competing Interest Statement

All authors are full-time employees and shareholders of Bluestar Genomics and have declared no other conflicts of interest.

Funding Statement

This work was supported by Bluestar Genomics. Bluestar Genomics was involved in the study design, study execution, analysis and interpretation (no grant number).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Sterling ; WIRB. The study protocol submission, IRB approval and specimen handling across all sites were managed by CROs who provided clinical research specimen handling services.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Grant Support: This work was supported by Bluestar Genomics. Bluestar Genomics was involved in the study’ s design, study execution, analysis and interpretation (no grant number).

  • Disclosures: All authors are full-time employees and shareholders of Bluestar Genomics and have declared no other conflicts of interest.

  • Writing Assistance: Medical writing support was provided by Tracy McNally and Ify Sargeant on behalf of Twist Medical and funded by Bluestar Genomics.

  • Writing Assistance: list names and funding source for individuals who provided writing assistance.

Data Availability

The Fastq files can be made available upon written request for submission to the study institutional review boards at the participating sites.

  • Abbreviations used in this paper

    5hmC
    5-hydroxymethylcytosine
    auROC
    area under the receiver operating characteristic curve
    CA19-9
    carbohydrate antigen 19-9
    cfDNA
    cell-free DNA
    CI
    confidence interval
    CPM
    counts per million
    CT
    computerized tomography
    EUS
    endoscopic ultrasound
    IPMN
    intraductal papillary mucinous neoplasm
    IRB
    Institutional Review Board
    KRAS
    Kirsten rat sarcoma virus
    MSigDB
    Molecular Signatures Database
    NA
    not available
    NES
    normalized enrichment score
    NOD
    new-onset diabetes
    OOPC
    out-of- panel cancer
    PaC
    pancreatic cancer
    PDAC
    pancreatic ductal adenocarcinoma
    QC
    quality control
    yo
    year old
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted December 29, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Using Cell-Free DNA 5-Hydroxymethylation Signatures
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Using Cell-Free DNA 5-Hydroxymethylation Signatures
    David Haan, Anna Bergamaschi, Gulfem D Guler, Verena Friedl, Yuhong Ning, Roman Reggiardo, Michael Kesling, Micah Collins, Bill Gibb, Adriana Pitea, Kyle Hazen, Steve Bates, Michael Antoine, Carolina Fraire, Vanessa Lopez, Roger Malta, Maryam Nabiyouni, Albert Nguyen, Tierney Phillips, Michael Riviere, Aaron Scott, Eric Nilson, Judy Sheard, Melissa Peters, Shimul Chowdhury, Wayne Volkmuth, Samuel Levy
    medRxiv 2021.12.27.21268450; doi: https://doi.org/10.1101/2021.12.27.21268450
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Using Cell-Free DNA 5-Hydroxymethylation Signatures
    David Haan, Anna Bergamaschi, Gulfem D Guler, Verena Friedl, Yuhong Ning, Roman Reggiardo, Michael Kesling, Micah Collins, Bill Gibb, Adriana Pitea, Kyle Hazen, Steve Bates, Michael Antoine, Carolina Fraire, Vanessa Lopez, Roger Malta, Maryam Nabiyouni, Albert Nguyen, Tierney Phillips, Michael Riviere, Aaron Scott, Eric Nilson, Judy Sheard, Melissa Peters, Shimul Chowdhury, Wayne Volkmuth, Samuel Levy
    medRxiv 2021.12.27.21268450; doi: https://doi.org/10.1101/2021.12.27.21268450

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Genetic and Genomic Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (215)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1093)
    • Dentistry and Oral Medicine (195)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
    • Epidemiology (9757)
    • Forensic Medicine (5)
    • Gastroenterology (480)
    • Genetic and Genomic Medicine (2303)
    • Geriatric Medicine (222)
    • Health Economics (462)
    • Health Informatics (1553)
    • Health Policy (732)
    • Health Systems and Quality Improvement (602)
    • Hematology (236)
    • HIV/AIDS (501)
    • Infectious Diseases (except HIV/AIDS) (11631)
    • Intensive Care and Critical Care Medicine (616)
    • Medical Education (236)
    • Medical Ethics (67)
    • Nephrology (256)
    • Neurology (2139)
    • Nursing (134)
    • Nutrition (335)
    • Obstetrics and Gynecology (426)
    • Occupational and Environmental Health (517)
    • Oncology (1172)
    • Ophthalmology (363)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (145)
    • Palliative Medicine (50)
    • Pathology (309)
    • Pediatrics (694)
    • Pharmacology and Therapeutics (298)
    • Primary Care Research (265)
    • Psychiatry and Clinical Psychology (2172)
    • Public and Global Health (4645)
    • Radiology and Imaging (775)
    • Rehabilitation Medicine and Physical Therapy (455)
    • Respiratory Medicine (623)
    • Rheumatology (274)
    • Sexual and Reproductive Health (225)
    • Sports Medicine (208)
    • Surgery (250)
    • Toxicology (43)
    • Transplantation (120)
    • Urology (94)